Effectiveness and cost-effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility

Literature review
21 Mar 2017
Cite:

European Centre for Disease Prevention and Control. Effectiveness and cost-effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility. Stockholm: ECDC; 2017.

​This literature review of the effectiveness and cost-effectiveness of antenatal screening was conducted as part of a project evaluating the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in EU/EEA Member States. The purpose of this review was to provide evidence for guidance to strengthen antenatal screening programmes in Europe.